Nationwide Registry of Pulsed Field Ablation Procedures for Atrial Arrhythmias in Poland Tracking Safety and Effectiveness Over 12 Months

What this Trial Is About

Researchers are establishing a nationwide registry in Poland to collect data on atrial arrhythmia ablation procedures using Pulsed Field Ablation PFA. This tissue-selective method targets myocardial cells and has shown promise in treating paroxysmal atrial fibrillation and other arrhythmias such as atrial flutter, atrial tachycardia, and ventricular tachycardia. The registry aims to expand knowledge about the safety and effectiveness of PFA beyond pulmonary vein isolation. The registry includes patients undergoing PFA ablation procedures tailored to their specific arrhythmias. Participation involves standard clinical care without additional procedures during hospitalization. Following the ablation, patients will be monitored for 12 months through telephone interviews at 3, 6, and 12 months. If needed, in-person evaluations may be conducted at the treatment center. Participants will contribute clinical data to better understand procedural techniques and outcomes. Researchers will measure the recurrence of supraventricular arrhythmias over a 12-month period. This registry will support future clinical trials and is coordinated by the Institute for Heart Diseases at the Jan Mikulicz-Radecki University Hospital, with participation from multiple centers performing PFA in Poland.

Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland